Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Astrocytoma, Malignant clinical trials
3 of 3 indexed Astrocytoma, Malignant trials are currently recruiting.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 3 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Astrocytoma, Malignant: 3 US clinical trials tracked, 3 recruiting.
Astrocytoma, Malignant is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. The most active sponsor is Jasper Gerritsen, running 2 of these trials.
Enrollment posture brief
Registry condition astrocytoma-malignant
OPEN 3 | RECR 100% | LATE 0 | EARLY 0 | RANK #5209 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Astrocytoma, Malignant lists 3 open slots (100% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Astrocytoma, Malignant on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Astrocytoma, Malignant is recruiting above its size-band peers.
3 of 3 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
Jasper Gerritsen
NCT06118723
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
Jasper Gerritsen
NCT06283927
The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
Erasmus Medical Center
NCT06273176
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Astrocytoma, Malignant records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Astrocytoma, Malignant trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Astrocytoma, Malignant page
3 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Astrocytoma, Malignant trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Jasper Gerritsen sponsors the most Astrocytoma, Malignant trials on record, review their full trial history before evaluating a specific study. See Jasper Gerritsen's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Astrocytoma, Malignant condition card totals 3 registered trials; most-linked intervention Resection under general anesthesia without mapping; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.